BIOMAT Database Logo BIOMAT Database Logo

Benzoylalanine analogues as inhibitors of rat brain kynureninase and kynurenine 3-hydroxylase. 1996

A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Pharmacia, R&D-CNS, Milano, Italy.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009525 Niacin A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties. Nicotinic Acid,3-Pyridinecarboxylic Acid,Enduracin,Induracin,Lithium Nicotinate,Niacin Aluminum Salt,Niacin Ammonium Salt,Niacin Calcium Salt,Niacin Cobalt (2+) Salt,Niacin Copper (2+) Salt,Niacin Hydrochloride,Niacin Iron (2+) Salt,Niacin Lithium Salt,Niacin Lithium Salt, Hemihydrate,Niacin Magnesium Salt,Niacin Manganese (2+) Salt,Niacin Potassium Salt,Niacin Sodium Salt,Niacin Tartrate,Niacin Tosylate,Niacin Zinc Salt,Nicamin,Nico-400,Nicobid,Nicocap,Nicolar,Nicotinate,Wampocap,3 Pyridinecarboxylic Acid,Aluminum Salt, Niacin,Hydrochloride, Niacin,Nico 400,Nico400,Nicotinate, Lithium,Potassium Salt, Niacin,Sodium Salt, Niacin,Tartrate, Niacin,Tosylate, Niacin
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006867 Hydrolases Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases (GLYCOSIDE HYDROLASES), lipases, NUCLEOTIDASES, peptidases (PEPTIDE HYDROLASES), and phosphatases (PHOSPHORIC MONOESTER HYDROLASES). EC 3. Hydrolase
D006899 Mixed Function Oxygenases Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation. Hydroxylase,Hydroxylases,Mixed Function Oxidase,Mixed Function Oxygenase,Monooxygenase,Monooxygenases,Mixed Function Oxidases,Function Oxidase, Mixed,Function Oxygenase, Mixed,Oxidase, Mixed Function,Oxidases, Mixed Function,Oxygenase, Mixed Function,Oxygenases, Mixed Function
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001565 Benzoates Derivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure. Benzoate,Benzoic Acids,Acids, Benzoic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Kynureninase and kynurenine 3-hydroxylase in mammalian tissues.
January 1991, Advances in experimental medicine and biology,
A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase.
August 1996, Journal of neurochemistry,
A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Kynurenine hydroxylase and kynureninase inhibitors as tools to study the role of kynurenine metabolites in the central nervous system.
January 1996, Advances in experimental medicine and biology,
A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia.
January 1999, Advances in experimental medicine and biology,
A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.
July 1994, Neuroscience,
A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Tryptophan Metabolism in Rat Liver After Administration of Tryptophan, Kynurenine Metabolites, and Kynureninase Inhibitors.
January 2016, International journal of tryptophan research : IJTR,
A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Presence of kynurenine hydroxylase in developing rat brain.
March 1981, Journal of neurochemistry,
A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Kynurenine-3-hydroxylase and its selective inhibitors. Molecular modeling studies.
January 1996, Advances in experimental medicine and biology,
A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Enzymatic assay of kynurenine and 3-hydroxykynurenine with Neurospora or Pseudomonas kynureninase.
September 1973, Clinica chimica acta; international journal of clinical chemistry,
A Giordani, and L Corti, and M Cini, and M Marconi, and A Pillan, and R Ferrario, and R Schwarcz, and P Guidetti, and C Speciale, and M Varasi
Localization and some properties of kynurenine-3-hydroxylase and kynurenine aminotransferase.
July 1971, The American journal of clinical nutrition,
Copied contents to your clipboard!